ArticleBioactive materials2026
Reconstructing the ischemic osteogenic microenvironment through hierarchical scaffolds orchestrating Mg
Article in Bioactive materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Neuropilin‑1: Emerging roles in nerve‑vessel‑bone coupling during fracture repair (Review).International journal of molecular medicine · 2026Review
- Advancements in pediatric tissue engineering: scaffold-based and cell-driven approaches.Cell and tissue banking · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ischemic bone defects remain a major challenge in bone tissue engineering, primarily due to insufficient angiogenesis caused by severely compromised local blood supply. Here, we develop a bioactive implant that mechanistically amplifies magnesium-induced angiogenesis by integrating pro-angiogenic liposomes encapsulating neuropilin-1 (NRP-1) with a 3D-printed magnesium (Mg) alloy porous scaffold. The customized Mg scaffold matched defect morphology, provided reliable mechanical support, and featured interconnected micropores to facilitate bone ingrowth and integration. Composite surface coatings simultaneously moderated the rapid degradation of Mg and supplied abundant binding sites for NRP-1-loaded lipos, enabling coordinated regulation of angiogenesis and osteogenesis. In an ischemic bone defect model, the scaffold significantly enhanced neovascularization, bone formation density, and interfacial osseointegration. Mechanistically, the controlled release of Mg
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.